logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Handbook Of Her2targeted Agents In Breast Cancer 2nd Edition Ricardo H Alvarez

  • SKU: BELL-5483250
Handbook Of Her2targeted Agents In Breast Cancer 2nd Edition Ricardo H Alvarez
$ 31.00 $ 45.00 (-31%)

4.4

32 reviews

Handbook Of Her2targeted Agents In Breast Cancer 2nd Edition Ricardo H Alvarez instant download after payment.

Publisher: ADIS
File Extension: PDF
File size: 2.67 MB
Pages: 117
Author: Ricardo H Alvarez, Javier Cortés, Mary Falzon, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart (auth.)
ISBN: 9783319282145, 9783319282169, 331928214X, 3319282166
Language: English
Year: 2016
Edition: 2

Product desciption

Handbook Of Her2targeted Agents In Breast Cancer 2nd Edition Ricardo H Alvarez by Ricardo H Alvarez, Javier Cortés, Mary Falzon, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart (auth.) 9783319282145, 9783319282169, 331928214X, 3319282166 instant download after payment.

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.

Related Products